Kamada (KMDA) vs MapLight Therapeutics (MPLT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
MapLight Therapeutics is the larger company by market cap ($490.7 million vs $466.3 million), about 1.1 times the size. Kamada pays a dividend yielding 3.09%, while MapLight Therapeutics does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KMDA | MPLT |
|---|---|---|
| Share price | $8.08 | $8.83 |
| Market cap | $466.30M | $490.73M |
| 1-day change | +3.92% | -3.50% |
| YTD return | +14.45% | -49.73% |
| 1-year return | +16.59% | — |
| 5-year return | +53.32% | — |
| P/E ratio (TTM) | 20.20 | — |
| Forward P/E | 14.01 | — |
| EPS (TTM) | $0.40 | $-6.25 |
| Dividend yield | 3.09% | 0.00% |
| Annual dividend | $0.25 | $0.00 |
| 52-week high | $9.35 | $40.43 |
| 52-week low | $6.55 | $8.71 |
| Distance from 52-week high | -13.58% | -78.16% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +67.08% | +200.57% |
| Average volume | 120.34K | 851.70K |
| Shares outstanding | 57.71M | 52.85M |
| Employees | 462 | 133 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Kamada offers a meaningfully higher dividend yield (3.09% vs 0.00%).
About Kamada
KMDA stock →Kamada Ltd. manufactures and sells plasma-derived protein therapeutics.
Health Care · Biotechnology: Pharmaceutical Preparations · 462 employees
About MapLight Therapeutics
MPLT stock →MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders.
Health Care · Biotechnology: Pharmaceutical Preparations · 133 employees
KMDA vs MPLT FAQ
Which is bigger, Kamada or MapLight Therapeutics?
MapLight Therapeutics (MPLT) is larger, with a market capitalization of $490.73M compared with $466.30M for Kamada (KMDA).
Which pays a higher dividend, Kamada or MapLight Therapeutics?
Kamada pays a dividend yielding 3.09%, while MapLight Therapeutics does not currently pay a regular dividend.
Are Kamada and MapLight Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.